Cargando…
Advancing host-directed therapy for tuberculosis: new therapeutic insights from the Toxoplasma gondii
Tuberculosis (TB) drug-development strategies, a wide range of candidate host-directed therapies (HDT)s-including new and repurposed drugs, biologics, and cellular therapies-have been proposed to accelerate eradication of infection and overcome the problems associated with current treatment regimens...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shared Science Publishers OG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349197/ https://www.ncbi.nlm.nih.gov/pubmed/28357397 http://dx.doi.org/10.15698/mic2017.03.565 |